Oct 01, 2018
Phospholipase Enzyme Market is Projected to Increase at a CAGR of 6.7% During the Forecast Period 2018-2028
May 31, 2018
IDELVION® Newly Approved 3500 IU Vial to Provide Convenience to Patients Using Larger Volumes
May 21, 2018
Head-to-head pharmacokinetic study demonstrated greater factor IX activity with Rebinyn® versus rFIXFc in people with hemophilia B
Apr 20, 2018
Prime Therapeutics Finds Costs Double When Switching to New Extended Half-Life Hemophilia Factor Products
Mar 22, 2018
United Neuroscience Signs Collaboration Agreement with French National Center for Scientific Research (CNRS) Laboratory to Target Protein Associated with Parkinson's Disease
Feb 22, 2018
Shedding a Tear May Help Diagnose Parkinson's Disease
Feb 08, 2018
Novo Nordisk Launches Rebinyn® in the United States for People with Hemophilia B
Dec 05, 2017
ICBII Announces the Filing of Orphan Drug Designation Application for the Use of a-Synuclein-SMART Molecule in the Treatment of Multiple System Atrophy
Dec 01, 2017
Asia-Pacific $1.49 Billion Hemophilia A and B Therapeutics Market to 2023
Nov 22, 2017
Global Alpha Synuclein Market Competition by Top Manufacturers - ReportsnReports
Nov 21, 2017
Phase 3 MURANO Study of Venetoclax Chosen as Late-Breaking Abstract at the 2017 American Society of Hematology Annual Meeting & Exposition, Highlighting AbbVie's Commitment to Helping Blood Cancer Patients
Nov 08, 2017
Vigene Biosciences Partners with The Michael J. Fox Foundation to Distribute Alpha-synuclein Knockdown Viral Vectors for Parkinson's Disease Research